ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences first quarter 2023 earnings call.
Reshape Weightloss Inc. (RSLS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | Large Shareholder | 5,330,277 | 2020-12-04 | Filing | |
| $4.13 | 5,400 | Large Shareholder | 5,330,277 | 2020-12-04 | Filing | |
| $0.00 | 0 | Large Shareholder | 5,324,877 | 2020-12-02 | Filing | |
| $4.31 | 1,000 | Large Shareholder | 5,324,877 | 2020-12-02 | Filing | |
| $0.00 | 0 | Large Shareholder | 5,323,877 | 2020-11-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 20,487 | Director | 26,200 | 2017-12-19 | Filing | |
| $4.85 | 97 | Director | 0 | 2017-05-25 | Filing | |
| $4.85 | 4,571 | Director | 0 | 2017-05-25 | Filing | |
| $4.85 | 97 | Director | 0 | 2017-05-25 | Filing | |
| $4.85 | 4,571 | Director | 0 | 2017-05-25 | Filing |
Institutional Investors' Holdings
News See All
Billionaire Hedge Funds
